5 months ago
TMO
AnalystsDaniel AriasDaniel Arias's Stock Forecasts
AnalystsDaniel Arias
Analyst Ranking
Top 16%
#820 out of 5290 analysts
Average Return
+10.19%
Win Rate
53%47 out of 88
Risk vs Reward
Poor
Good
Daniel Arias's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nanostring Technologies IncNSTGQ | +198.16% | $22.86 | $68.16 | 2020-04-01 - 2021-04-01 | Strong Buy |
908 Devices IncMASS | +152.14% | $2.34 | $5.90 | 2024-11-12 - 2025-11-12 | Strong Buy |
Guardant Health IncGH | +140.49% | $42.87 | $103.10 | 2025-02-20 - 2026-02-20 | Strong Buy |
Exact Sciences CorpEXAS | +130.17% | $57.60 | $132.58 | 2020-04-01 - 2021-04-01 | Strong Buy |
Tempus Ai IncTEM | +124.99% | $34.50 | $77.62 | 2024-07-08 - 2024-11-11 | Strong Buy |
Daniel Arias Analyst Color
Get additional color on Daniel Arias's coverage of popular stocks
5 months ago
GH
7 months ago
EXAS
8 months ago
GH
a year ago
GH
2 years ago
TMO
2 years ago
AVTR
2 years ago
TMO
2 years ago
RGEN
3 years ago
TXG
Daniel Arias's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Qiagen NvQGEN | 5 | Hold | $36.00 | -1.23% | Maintains | 18 days ago |
Mettler Toledo International IncMTD | 8 | Strong Buy | $1,400.00 | +19.73% | Maintains | 18 days ago |
Alamar Biosciences IncALMR | 1 | Strong Buy | $28.00 | +33.72% | Initiates Coverage On | 24 days ago |
Revvity IncRVTY | 5 | Hold | $100.00 | -1.06% | Maintains | a month ago |
Thermo Fisher Scientific IncTMO | 14 | Strong Buy | $600.00 | +26.60% | Maintains | a month ago |
10x Genomics IncTXG | 8 | Strong Buy | $25.00 | -22.26% | Maintains | 3 months ago |
Guardant Health IncGH | 6 | Strong Buy | $130.00 | +2.34% | Maintains | 4 months ago |
Bio Techne CorpTECH | 12 | Hold | $65.00 | +27.83% | Maintains | 4 months ago |
Illumina IncILMN | 12 | Strong Buy | $155.00 | -9.32% | Maintains | 5 months ago |
Billiontoone IncBLLN | 1 | Strong Buy | $145.00 | +47.42% | Initiates Coverage On | 6 months ago |
Exact Sciences CorpEXAS | 7 | Hold | $105.00 | -94.37% | Downgrades | 6 months ago |
Bruker CorpBRKR | 7 | Hold | $40.00 | -36.20% | Maintains | 10 months ago |
Avantor IncAVTR | 7 | Hold | $12.00 | +32.30% | Maintains | 10 months ago |
Danaher CorpDHR | 6 | Strong Buy | $260.00 | N/A | Upgrades | a year ago |
Maxcyte IncMXCT | 2 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
908 Devices IncMASS | 2 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Tempus Ai IncTEM | 2 | Hold | $65.00 | N/A | Downgrades | 2 years ago |
Waters CorpWAT | 11 | Hold | $360.00 | N/A | Maintains | 2 years ago |
Agilent Technologies IncA | 13 | Strong Buy | $151.00 | N/A | Maintains | 2 years ago |
Maravai Lifesciences Holdings IncMRVI | 2 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Repligen CorpRGEN | 6 | Strong Buy | $207.00 | N/A | Maintains | 2 years ago |
Codexis IncCDXS | 2 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
Phenomex IncCELL | 3 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Somalogic IncSLGC | 2 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Renalytix PLCRNLXY | 2 | Strong Buy | $7.00 | N/A | Maintains | 4 years ago |
Absci CorpABSI | 2 | Hold | $10.00 | N/A | Maintains | 4 years ago |
Nanostring Technologies IncNSTGQ | 1 | Strong Buy | $35.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.